Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-04-17 00:00:00 ET · period of report 2023-04-17 · accession 0001415889-23-006577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | 2023-04-17 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.94 | +1,700 | 33.8K | +5% | +$4,998 | |
| 2023-04-17 | 2023-04-17 | FENC | RALLIS CHRIS A | Dir | F - Tax | $8.34 | -986 | 32.8K | -3% | -$8,223 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-04-17 | M | A | 1,700 | $2.94 | 33,777 | D | — | — | (F1) Represents options granted May 17, 2013, with a $2.94 strike price aand expiration of May 17, 2023. |
| 2 | Common | Common Shares | 2023-04-17 | F | D | 986 | $8.34 | 32,791 | D | — | — | (F2) Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligation in connectionwith the exercise of 1,700 shares from a May 2013 grant. |